Misonix (MSON) Tops Q2 EPS by 8c, Revenues Beat

Go back to Misonix (MSON) Tops Q2 EPS by 8c, Revenues Beat

Misonix Fiscal 2019 Second Quarter Revenue Rises 22% to a Record $10.2 Million

February 6, 2019 4:05 PM EST

FARMINGDALE, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (Misonix or the Company), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today reported financial results for the fiscal 2019 second quarter ended December 31, 2018 as summarized below:

 Three Months Ended Six Months Ended December... More